Dale Bredesen, MD discusses the recent FDA approval of Biogen’s drug, aducanamab marketed as Aduhelm and the truth behind the research in a recent Facebook Live event. Click here to watch now
Dale Bredesen, MD discusses the recent FDA approval of Biogen’s drug, aducanamab marketed as Aduhelm and the truth behind the research in a recent Facebook Live event. Click here to watch now